Rowland Bryan T.r. - 19 Mar 2025 Form 4 Insider Report for Vertex, Inc. (VERX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
21 Mar 2025, 16:03:16 UTC
Prior SEC filing
04 Mar 2025
Next SEC filing
12 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Lisa Coleman, Attorney-in-Fact

Key filing fact

Rowland Bryan T.r. filed Form 4 for Vertex, Inc. (VERX) on 21 Mar 2025.

Key facts

  • This page summarizes Rowland Bryan T.r.'s Form 4 filing for Vertex, Inc. (VERX).
  • 6 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 21 Mar 2025, 16:03.

Change

  • Previous filing in this sequence was filed on 04 Mar 2025.
  • Current net transaction value: -$1,407,010.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VERX transaction

Class A Common Stock

Options Exercise

Transaction value
$116,120
Shares
+31,098
Change %
+276%
Price
$3.73
Shares after
42,353
Date
19 Mar 2025
Ownership
Direct
VERX transaction

Class A Common Stock

Options Exercise

Transaction value
$32,385
Shares
+1,007
Change %
+2.4%
Price
$32.16
Shares after
43,360
Date
19 Mar 2025
Ownership
Direct
VERX transaction

Class A Common Stock

Sale

Transaction value
$677,221
Shares
-18,982
Change %
-44%
Price
$35.68
Shares after
24,378
Date
19 Mar 2025
Ownership
Direct
Footnotes
F1, F2
VERX transaction

Class A Common Stock

Sale

Transaction value
$878,294
Shares
-24,246
Change %
-99%
Price
$36.22
Shares after
132
Date
19 Mar 2025
Ownership
Direct
Footnotes
F1, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VERX transaction Derivative

Stock Option

Options Exercise

Transaction value
$0
Shares
-31,098
Change %
-100%
Price
$0.000000
Shares after
0
Date
19 Mar 2025
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
31,098
Exercise price
$3.73
Footnotes
F4
VERX transaction Derivative

Stock Option

Options Exercise

Transaction value
$0
Shares
-1,007
Change %
-100%
Price
$0.000000
Shares after
0
Date
19 Mar 2025
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
1,007
Exercise price
$32.16
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 4 footnotes

Footnote F1

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $35.00 to $35.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Footnote F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $36.00 to $36.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Footnote F4

This option is fully vested and exercisable.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .